Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population
To access this article, please choose from the options below
PII: S0021-9150(05)00441-7
doi:10.1016/j.atherosclerosis.2005.06.033
© 2005 Elsevier Ireland Ltd. All rights reserved.
